Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
The radiotherapy treatment comes from an electrical machine called a ‘Linear accelerator’ and is directed as a beam to the part of the body that needs to be treated. Treatment is given daily over a period of days or weeks and you may hear people call these treatments ‘fractions’. They are just a fraction of your treatment dose and plan.
Chemotherapy at the Rutherford takes place in our modern therapy suites, consisting of up to ten treatment areas offering treatment for haematology/oncology patients requiring systemic anti-cancer therapy (SACT) and supportive care in an outpatient setting. The infusion therapy suites are available for patients undergoing treatment for breast, urology, upper and lower gastrointestinal cancers, and both malignant and non-malignant haematology disorders.
Dr Emma Hudson is a consultant in Clinical Oncology with almost a decade of experience specialising in the treatment of all aspects of gynaecological (ovarian, cervical, endometrial, vulva) and lung cancers. Her clinical research interests include the use of novel agents in ovarian and cervical cancer and small cell cancer, particularly extra pulmonary small cell. She has a strong research background with a 1st class honours in Clinical Pharmacology and has published extensively in peer reviewed journals.
Dr Emma Hudson is the UK Chief Investigator of the AtTEnd trial, an international multicentre NCRI endorsed trial which is in development and Principal Investigator of multiple national trials in ovarian, endometrial and cervical cancer. She has been invited to attend ENGOT gynaecological cancer academy workshops and is a reviewer for the Journal of Obstetrics and Gynaecology.
Outside of work Dr Emma Hudson spends time with her two young children and rescue dogs, enjoying the great outdoors doing various activities such as cycling, sailing, cross country skiing, playing tennis or walking in the wonderful mountains and coastal pathways of Wales. She's also been involved in extensive charity work for Velindre Cancer Centre, and, some of her plights include running the Cardiff Half Marathon, climbing Kilimanjaro and cycling across North America and Canada.
Member of the trials management group of several trials including STATEC, CEBOC and PAZOFOS
Member on the tumour Specific Expert Panel of the Macmillan Horizons project for Gynaecology
Member of GMC
Member of FRCR
Dr Emma Hudson does not hold a share or financial interest in the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Emma Hudson does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Emma Hudson does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Rutherford Health plc.
Get in Touch
If you'd like to speak to us about any of the treatments we offer please don’t hesitate to get in touch. Call us on 0800 210 0402 or